Validation of the EGS usercode DOSE3D for internal beta dose calculation at the cellular and tissue levels.
暂无分享,去创建一个
[1] D. R. Anderson,et al. Preclinical evaluation of 90Y-labeled anti-CD20 monoclonal antibody for treatment of non-Hodgkin's lymphoma. , 1999, International journal of oncology.
[2] J. Gillis,et al. Methods in Computational Physics , 1964 .
[3] J L Humm,et al. Estimate of absorbed dose based on two-dimensional autoradiographic information in internal radionuclide therapy. , 2001, Medical physics.
[4] W G Cross,et al. Beta-ray dose distributions from point sources in an infinite water medium. , 1992, Health physics.
[5] H. Atkins,et al. Assessment of thyroid function and anatomy with technetium-99m as pertechnetate. , 1968, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[6] M Berman,et al. A schema for absorbed-dose calculations for biologically-distributed radionuclides. , 1968, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[7] A. Kassis. The MIRD approach: remembering the limitations. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[8] D. Fisher. Radiation dosimetry for radioimmunotherapy. An overview of current capabilities and limitations , 1994, Cancer.
[9] J L Humm,et al. Image analysis for the study of radionuclide distribution in tissue sections. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[10] David W. O. Rogers,et al. Presta: The parameter reduced electron-step transport algorithm for electron monte carlo transport , 1986 .
[11] M G Stabin,et al. MIRDOSE: personal computer software for internal dose assessment in nuclear medicine. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[12] Walter R. Nelson,et al. Geometry Methods and Packages , 1988 .
[13] L. Gordon,et al. Phase I/II trial of IDEC-Y2B8 radioimmunotherapy for treatment of relapsed or refractory CD20(+) B-cell non-Hodgkin's lymphoma. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] Thomas F. Budinger,et al. MIRD primer for absorbed dose calculations , 1988 .
[15] I Clairand,et al. DOSE3D: EGS4 Monte Carlo code-based software for internal radionuclide dosimetry. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[16] A L Boyer,et al. Validation of a dose-point kernel convolution technique for internal dosimetry , 1995, Physics in medicine and biology.
[17] P Andreo,et al. Constraints of the multiple-scattering theory of Molière in Monte Carlo simulations of the transport of charged particles. , 1993, Medical physics.
[18] M H Loew,et al. Use of the fast Hartley transform for three-dimensional dose calculation in radionuclide therapy. , 1998, Medical physics.
[19] H. Paul. Shapes of beta spectra , 1966 .
[20] R. Toohey,et al. Radiation dose distributions in normal tissue adjacent to tumors containing (131)I or (90)Y: the potential for toxicity. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[21] David W. O. Rogers,et al. A Comparison of EGS and ETRAN , 1988 .
[22] Stephen M. Seltzer,et al. An Overview of ETRAN Monte Carlo Methods , 1988 .
[23] P. Zanzonico,et al. Internal radionuclide radiation dosimetry: a review of basic concepts and recent developments. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[24] D. Goldenberg. Targeted therapy of cancer with radiolabeled antibodies. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[25] G. A. Bruno,et al. Retention of 113mIn-59Fe-ferric hydroxide in the mouse. , 1971, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[26] C S Chui,et al. A Monte Carlo approach to patient-specific dosimetry. , 1996, Medical physics.
[27] L. M. Cobb,et al. Internal dosimetry using data derived from autoradiographs. , 1993, Journal of Nuclear Medicine.
[28] W E Bolch,et al. MIRD pamphlet No. 17: the dosimetry of nonuniform activity distributions--radionuclide S values at the voxel level. Medical Internal Radiation Dose Committee. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[29] E. Yorke,et al. Treatment planning for radio-immunotherapy. , 1996, Physics in medicine and biology.
[30] T. Mackie,et al. EGS4 Monte Carlo determination of the beta dose kernel in water. , 1990, Medical physics.
[31] P. Mountford. Internal dosimetry: developments and limitations , 1996, European Journal of Nuclear Medicine.
[32] I. Kawrakow. Accurate condensed history Monte Carlo simulation of electron transport. I. EGSnrc, the new EGS4 version. , 2000, Medical physics.
[33] R K Ten Haken,et al. Three‐dimensional reconstruction of monoclonal antibody uptake in tumor and calculation of beta dose‐rate nonuniformity , 1994, Cancer.
[34] Klemens Scheidhauer,et al. Biodistribution and kinetics of 131I-labelled anti-CD20 MAB IDEC-C2B8 (rituximab) in relapsed non-Hodgkin's lymphoma , 2002, European Journal of Nuclear Medicine and Molecular Imaging.
[35] L. Gordon,et al. Radioimmunotherapy of relapsed non-Hodgkin's lymphoma with zevalin, a 90Y-labeled anti-CD20 monoclonal antibody. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.